Back to Treatments

Treatment

Treprostinil (Parenteral/Inhaled)

1
Conditions
1
Trials
8,000
Participants
30%
Average Safety

Condition Evidence

Pulmonary Arterial Hypertension

1 trials · 8,000 participants

90% effectiveness · 30% safety
Treprostinil (Parenteral/Inhaled) | DFDA